Atrys Health SL Market Cap ($204.95 Million)
Market Cap & Net Worth: Atrys Health SL (ATRY)
Atrys Health SL market cap. Atrys Health SL (MC:ATRY) has a market capitalization of $204.95 Million (€175.31 Million) as of November 8, 2026. Listed on the MC stock exchange, this Spain-based company holds position #16206 globally and #108 in its home market, demonstrating a 0.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Atrys Health SL's stock price €2.65 by its total outstanding shares 75908655 (75.91 Million). Also see Atrys Health SL cash flow conversion for how efficiently the company converts equity into cash flow.
Atrys Health SL Market Cap History (2016–2026)
Atrys Health SL market cap history from 2016 to 2026. Data shows growth from $120.42 Million to $235.17 Million (5.91% CAGR). Check ATRY live share price for real-time trading data and today's change.
Atrys Health SL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Atrys Health SL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Atrys Health SL equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.84x
Atrys Health SL's market cap is 1.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $120.42 Million | $5.96 Million | $63.04K | 20.20x | 1910.13x |
| 2017 | $174.93 Million | $8.03 Million | $290.94K | 21.79x | 601.27x |
| 2018 | $245.03 Million | $7.29 Million | $11.98K | 33.59x | 20445.09x |
| 2019 | $443.73 Million | $14.84 Million | -$104.78K | 29.91x | N/A |
| 2020 | $789.83 Million | $33.81 Million | -$5.55 Million | 23.36x | N/A |
| 2021 | $900.76 Million | $121.01 Million | -$23.20 Million | 7.44x | N/A |
| 2022 | $550.22 Million | $158.37 Million | -$23.15 Million | 3.47x | N/A |
| 2023 | $325.69 Million | $201.57 Million | -$45.59 Million | 1.62x | N/A |
| 2024 | $299.07 Million | $212.74 Million | -$31.77 Million | 1.41x | N/A |
| 2025 | $260.02 Million | $141.01 Million | -$100.30 Million | 1.84x | N/A |
Competitor Companies of ATRY by Market Capitalization
Companies near Atrys Health SL in the global market cap rankings as of November 8, 2026. Also see Atrys Health SL balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Atrys Health SL by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Atrys Health SL (2016–2026)
Market capitalization of Atrys Health SL from 2016 to today. Between 2016 and today, Atrys Health SL's market cap moved from $120.42 Million to $ 235.17 Million, with a yearly change of 5.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €235.17 Million | -9.56% |
| 2025 | €260.02 Million | -13.06% |
| 2024 | €299.07 Million | -8.17% |
| 2023 | €325.69 Million | -40.81% |
| 2022 | €550.22 Million | -38.92% |
| 2021 | €900.76 Million | +14.04% |
| 2020 | €789.83 Million | +78.00% |
| 2019 | €443.73 Million | +81.09% |
| 2018 | €245.03 Million | +40.07% |
| 2017 | €174.93 Million | +45.27% |
| 2016 | €120.42 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Atrys Health SL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $204.95 Million USD |
| MoneyControl | $204.95 Million USD |
| MarketWatch | $204.95 Million USD |
| marketcap.company | $204.95 Million USD |
| Reuters | $204.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fi… Read more